Close Menu

NEW YORK ─ Todos Medical said on Tuesday that it has entered into an agreement to become the provider of all COVID-19 PCR testing reagents and supplies for Majl Diagnostics.

Rehovot, Israel-based Todos said that it will install its automation equipment, including Tecan liquid handlers, automated RNA extraction machines, and 384-well PCR platforms, which are used for COVID-19, cancer genetics, and pharmacogenomics testing.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.